Delta4ai

When it comes to drug repurposing, taking a patient-centered approach is key to achieve safe, efficient and precise cures. But how can we work more efficiently with patient organisations to make this a reality? Meet the panellists who will be sharing their views on this and other key topics at our upcoming hybrid event, focused on exploring innovative and sustainable models for drug repurposing in Europe 👉 https://lnkd.in/eFx-XYCA Session 1: The patients’ and patient organisations’ view 🟣 Marcos Mengual Hinojosa - SYNGAP Elternhilfe e.V. 🟣 Anneliene Jonker - Duchenne Parent Project 🟣 Ellen Koekoeckx - Foundation for Angelman Syndrome Therapeutics 🟣 Joachim Maurice Mielert - Aktionsbündnis Patientensicherheit e. V. 🟣 Bernd Rosenbichler - Branewo Check the full agenda, and sign up to attend in-person or online on 15 January ➡️ https://lnkd.in/eFx-XYCA 🇪🇺 #EUfunded by European Health and Digital Executive Agency (HaDEA) #DrugRepurposing #FutureOfMedicine #HealthcareInnovation

🔬 Smarter. Faster. Safer. At Delta4, we revolutionize drug discovery pipelines: ⏱️ Reduce time to market: Hyper-C identifies drug candidates with unmatched speed. 📈 Boost success rates: Focus on proven drugs and high-potential targets. 🔍 Transparent insights: Mechanism of action hypotheses aid regulatory approval. 🧬 Biomarker breakthroughs: Drive efficient and targeted clinical trials. The future of drug development is here—and it’s AI-powered. 💡💊 https://lnkd.in/dVQwAzhi #AIInDrugDiscovery #HyperC #HealthcareTech #PharmaInnovation #LifeSciences #Delta4

AI in Drug Development: A Powerful Tool, but not yet a complete solution. In our latest discussion, we dive into the evolving role of AI in drug development. While AI has made impressive strides with specialized tools for tasks like: ✅ Optimizing clinical trial success probabilities ✅ Identifying small molecules for specific targets ✅ Enhancing molecular designs ... the process is still guided by human expertise. AI is currently a supplementary tool—a collection of specialized solutions. Even first attempts at end-to-end AI-based drug development require human oversight, particularly when progressing from in vitro data to animal validation and clinical studies. As we navigate this era of innovation, one thing is clear: the human-in-the-loop approach remains not only critical but necessary. Would you trust a fully machine-led clinical study? 🤔 For now, expertise and AI must work hand in hand. 🎧 Listen to the full insights here: https://lnkd.in/dSR4SKJ6 #DrugDevelopment #AIinHealthcare #PharmaInnovation #ClinicalTrials #ArtificialIntelligence

🌟 A fresh start into the New Year 2025! 🌟 With the help of Hyper-C, Delta4’s cutting-edge AI-powered platform, we help clients discover new indications for drugs with known safety profiles, saving time, cutting costs, and increasing success. ⏳💰 Every step of the way, our skilled computational biologists turn complex data into unique insights—bringing promising treatments to market faster than ever. 💊 https://delta4.ai/hyper-c/ #Delta4 #DrugDiscovery #AIInnovation #LifeSciences #HealthcareTech #Therapeutics #HyperC

Embrace 2025 with Hope! 🌟 Delta4 sends warm wishes for a year filled with boundless opportunities, achievements, enthusiasm and joy. We wish you a Happy and Healthy New Year! #NewYear #BrightFuture #Delta4

Merry Christmas from Delta4! 🎄✨ As we celebrate the joy and hope of this festive season, we’re reminded of the importance of health and well-being for all. From our team to yours, may your holidays be filled with peace, happiness, and good health. #Delta4 #HappyHolidays #HolidaySpirit

🎙️ AI Drug Development - Delta4's Roots From the early days in bioinformatics in the 2000s to today’s breakthroughs with AI and large language models, the journey has been clear: ✅ Grow from academic roots ✅ Professionalize approaches ✅ Bring precision-driven innovation to patients While AI excels at handling massive datasets, humans still lead in understanding context—for now. Tune in as we explore how machine learning is reshaping drug discovery and where human expertise meets algorithmic power in biomedical research. 🔗 Listen here: https://lnkd.in/dSR4SKJ6 #AI #Bioinformatics #DrugDiscovery #MachineLearning #HealthcareInnovation #AIInDrugDiscovery #Delta4 #LifeSciences #PharmaTech #HyperC #Podcast

🎙️At Delta4, we’re transforming drug discovery. In our latest podcast, we discuss how Hyper-C, our AI-powered platform, identifies untapped potential by mapping drug-disease connections and providing actionable, transparent insights—eliminating the “black box” problem. Hear how we’re helping pharma companies save time, cut costs, and bring life-changing treatments to patients faster. 💊 🎧 Listen now: https://lnkd.in/eTBqWmKc #Delta4Podcast #AIInHealthcare #DrugDiscovery #HyperC #LifeSciences #Therapeutics

🎉 The Delta4 team had an incredible night celebrating our yearly company Christmas dinner at the elegant TERRAE restaurant in Vienna's first district. 🥂🍽️ Here’s to another year of innovation, collaboration, and success in AI-powered drug discovery and indication expansion. Cheers to making the future healthier together! 🌟💊 #Delta4 #AIInnovation #DrugDiscovery #ChristmasDinner #FestiveSeason #TeamCelebration #Vienna #AIInHealthcare #LifeSciences #CompanyCulture

🌟 PerMediK Virtual Mobility Spotlight 🌟 We’re excited to highlight the exceptional work of Matthias Ley, whose Virtual Mobility Grant within the PerMediK Network focused on advancing Chronic Kidney Disease (CKD) research through innovative programming tools. Matthias conceptualized and developed a Python programming workshop tailored specifically for CKD research, equipping researchers with the skills and tools needed to analyze complex datasets and model disease mechanisms. His work aligns perfectly with PerMediK's mission of fostering collaboration and driving innovation in personalized medicine. Congrats to Matthias for this outstanding contribution to the network! #PerMediK #VirtualMobility #CKD #DataScience #PythonProgramming #PersonalizedMedicine #Collaboration Let us know if you'd like to learn more about Virtual Mobility Grants or share your own success story! 🚀 Delta4ai